Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity
Clinical trial NCT03145012 · COMPLETED
Trial details
- NCT number
- NCT03145012
- Sponsor
- Nova Scotia Health Authority
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-01
- Primary completion
- 2018-10-24
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.